EUVIMEDEUVIMED entdecken
Open Access

Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization

Chao Qian, Zhen Wang iD, Yan Xiong, Dingpeng Zhang iD, Yue Zhong, Hiroyuki Inuzuka, Yihang Qi, Ling Xie, Xian Chen, Wenyi Wei iD, Jian Jin iD

Journal of the American Chemical Society · 30.04.2025 · 147 (17) · 14564-14573

DOI: 10.1021/jacs.5c01662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 19.04.2025. Verfasst von Chao Qian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute…. Hauptthemen laut MEDLINE: Ubiquitin-Specific Proteases, Proteolysis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deubiquitinase-targeting chimera (DUBTAC) has emerged as a promising technology for targeted protein stabilization (TPS) by harnessing deubiquitinases (DUBs) to remove polyubiquitin chains from target proteins. Despite the presence of over 100 human DUBs, only OTUB1 and USP7 have been utilized in the development of DUBTAC. Hence, there is an urgent need to harness additional DUBs to expand the DUBTAC arsenal. In this work, we demonstrate for the first time that the USP1 deubiquitinase, which is overexpressed in several human cancers, can be leveraged for TPS. We report the development of novel USP1-recruiting DUBTACs by utilizing a noncovalent small-molecule inhibitor of USP1. First, we generated a USP1-based CFTR DUBTAC, MS5310, which effectively stabilized CFTR and is more potent than previously reported CFTR DUBTACs. Next, we developed first-in-class USP1-recruiting UTX DUBTACs, including MS7131, from a small-molecule inhibitor of UTX and JMJD3. Notably, MS7131 effectively stabilized the tumor suppressor UTX in a concentration- and time-dependent manner, while sparing the oncoprotein JMJD3, despite it retaining potent inhibition of JMJD3. Furthermore, UTX stabilization induced by MS7131 was dependent on the engagement of both USP1 and UTX. Consequently, MS7131, but not the parent USP1 inhibitor or UTX inhibitor, effectively reduced histone H3 lysine 27 trimethylation and significantly suppressed the proliferation and clonogenicity of cancer cells. Overall, this study highlights that USP1 can be harnessed for DUBTAC development. Moreover, we developed a valuable chemical tool, MS7131, for the investigation of UTX's distinct functions. This advancement paves the way for leveraging DUBTACs in the treatment of related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Specific ProteasesProteolysisDeubiquitinating EnzymesHumansNeoplasms

Substanzen

Deubiquitinating EnzymesUSP1 protein, humanUbiquitin-Specific Proteases

Autor:innen und Institutionen

  • Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, U…
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
  • Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Zhen Wang, Dingpeng Zhang, Wenyi Wei, Jian Jin

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • National Cancer Institute
  • Icahn School of Medicine at Mount Sinai
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Qian, C., Wang, Z., Xiong, Y., Zhang, D., Zhong, Y., Inuzuka, H., Qi, Y., Xie, L., Chen, X., Wei, W., & Jin, J. (2025). Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization. Journal of the American Chemical Society, 147(17), 14564-14573. https://doi.org/10.1021/jacs.5c01662

Vancouver

Qian C, Wang Z, Xiong Y, Zhang D, Zhong Y, Inuzuka H, et al. Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization. Journal of the American Chemical Society. 2025;147(17):14564-14573. doi:10.1021/jacs.5c01662

BibTeX
@article{Qian2025,
  author = {Qian, Chao and Wang, Zhen and Xiong, Yan and Zhang, Dingpeng and Zhong, Yue and Inuzuka, Hiroyuki and Qi, Yihang and Xie, Ling and Chen, Xian and Wei, Wenyi and Jin, Jian},
  title = {Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  volume = {147},
  number = {17},
  pages = {14564--14573},
  doi = {10.1021/jacs.5c01662}
}
Kostenlos starten →